Shaperon
Seoul
About Shaperon
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $22.8M
- Funding stage: IPO
- Last round: Series C (Oct 2020)
- Ticker: kosdaq:378800
- Website: shaperon.com
- Phone: 82 (0)2 6083 8302
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/shaperon-83310 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.